Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adapted Physical Activity in Patients With Resected Pancreatic Cancer (APACaPOp PRODIGE-56 Study): a National Multicenter Randomized Controlled Phase II Trial

NCT03400072 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.

NCT NCT03400072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03400072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adapted Physical Activity in Patients With Resected Pancreatic Cancer (APACaPOp PRODIGE-56 Study): a National Multicenter Randomized Controlled Phase II Trial
Lead sponsor
Centre Hospitalier Universitaire de Besancon
Phase
Not applicable
Overall status
Unknown status
Start date
August 3, 2018
Completion date
August 31, 2024
Enrollment
252 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer, quality of life